275P A phase II study of LAG525 in combination with spartalizumab (PDR001), PDR001 and carboplatin (Carbo), or Carbo, as first- or second-line therapy in patients (Pts) with advanced (Adv) triple-negative breast cancer (tnbc)
医学
肿瘤科
内科学
三阴性乳腺癌
卡铂
临床研究阶段
三重阴性
乳腺癌
一线治疗
作者
Lisa A. Carey,J-Y Pierga,Sherko Kümmel,G. Jerusalem,M. De Laurentiis,M. Miller,Z. Li,M. Kaper,Faye Su,Sherene Loi